Navigation Links
M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
Date:7/1/2008

The newly established Small Interfering Ribonucleic Acid (siRNA) Facility at M. D. Anderson Cancer Center has been charged with providing high-quality siRNA screening services for both internal and external customers.

HOUSTON (Business Wire EON) July 1, 2008 -- M. D. Anderson has chosen Stone Bond Technologies' EE-LIMS™ to document activities within the laboratory workflow at its siRNA facility, increasing throughput, while reducing the risk of errors, and providing automation for the management of operations in its siRNA Laboratory.

As one of the newest fields in the study of nucleic acids, small interfering RNA has shown considerable potential in laboratory studies to change how diseases are treated. Considering how difficult it is to work with these molecules and the specialized equipment devoted to their isolation and study, labs specializing in this area have a strong need to document the work that goes into producing genetic data that corresponds to the RNA in a given sample.

Stone Bond's LIMS is an award-winning Web-based laboratory information management system, recipient of the Bio-IT World magazine's Grand Prize winner for technical innovation in its annual Best Practice awards, in the category of IT Infrastructure and Informatics. Built on Stone Bond's powerful and versatile Enterprise Enabler integration platform, EE-LIMS automates laboratory workflows, invoicing, data and sample tracking, collections and other business processes to help laboratories reduce overhead and administrative costs.

"M. D. Anderson's siRNA laboratory's operations will be better tracked and managed, thanks to the support for complex workflow automation provided by our flexible LIMS solution, and Stone Bond's knowledge of siRNA processes and procedures," noted Pamela Szabo, Senior Vice-president and CIO at Stone Bond Technologies.

About Stone Bond Technologies

Founded in 2002, Stone Bond is based in Houston, Texas, with sales development offices in North America, Latin America and the Middle East. A leader in next generation e-commerce, workflow and integration technology, Stone Bond provides software solutions that help businesses improve their bottom line by streamlining interaction among business systems. Stone Bond's software suite, Enterprise Enabler®, is a commercially proven technology that significantly reduces delivery times and implementation costs. For more information on building a smart connected enterprise, contact Stone Bond by calling +1 713-622-8798, or visit us at www.stonebond.com


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
5. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
6. AviaraDx Announces CAP Accreditation of Its Laboratory Operations
7. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
8. New White Paper Details Six Steps to Investigate and Prevent Laboratory Accidents
9. Codexis Opens Singapore Laboratory
10. Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory
11. Ames Laboratory researchers solve fuel-cell membrane structure conundrum
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies :  EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks 
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):